Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4, Double-Blind, Multi-Center, Placebo-Controlled, Randomized Withdrawal, Safety and Efficacy Study of SPD489 in Adults Aged 18-55 With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00877487 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT00877487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00877487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4, Double-Blind, Multi-Center, Placebo-Controlled, Randomized Withdrawal, Safety and Efficacy Study of SPD489 in Adults Aged 18-55 With Attention-Deficit/Hyperactivity Disorder (ADHD)
Lead sponsor
Shire
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2009
Completion date
July 8, 2010
Enrollment
123 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

attention-deficit/hyperactivity disorder